Top Industry Leaders in the Immunoassay in R D Market
Latest Immunoassays in R and D Companies Update
-
Mar 2023: Leading global player in vitro diagnostics, bioMérieux, has invested strategically in Proxim Diagnostics Corp., an innovative business creating a portable point-of-care diagnostic tool. The money will be utilized to finish the development and launch Proxim's Profile System, a fully automated, mobile immunodiagnostic tool that uses disposable cartridges to perform multiplexed tests. Proxim is working on several immunoassays that will match the sensitivity and accuracy of tests conducted on more sophisticated, centralized laboratory equipment in infectious disease, cardiology, and sepsis. The company's portable device is anticipated to enhance the capacity of medical professionals to conduct quick, high-quality assessments at the point of care, such as in emergency rooms, critical care units, assisted living facilities, community/remote clinics, in-home care, and defense and disaster relief scenarios. Right now, the technology can only be used for study.
List of Immunoassays in R and D Key companies in the market
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Becton
- Dickinson and Company
- Danaher Corporation
- bioMérieux Inc.
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Sysmex Corporation
- Abcam plc